Squamous cell carcinoma of the head and neck (SCCHN) patients with low interleukin 6 (IL-6) and high MMP9, or with high IL-6 and low MMP9, were found to have the poorest outcomes followed by patients with both high IL-6 and high MMP9. This evidence concerns the gene MMP9 and head and neck squamous cell carcinoma.